Difference between revisions of "Team:TrinityCollegeDublin"
| Line 242: | Line 242: | ||
<div class="leftSeparator fadeIn"> <img src="https://static.igem.org/mediawiki/2015/3/31/TrinityDublin15_Separator_Blue3.png"> | <div class="leftSeparator fadeIn"> <img src="https://static.igem.org/mediawiki/2015/3/31/TrinityDublin15_Separator_Blue3.png"> | ||
</div> | </div> | ||
| − | + | <br><br><br><br> | |
<div class="standardMargin fadeIn centre"> | <div class="standardMargin fadeIn centre"> | ||
<h1 class="headingOne">E.artemisia</h1> | <h1 class="headingOne">E.artemisia</h1> | ||
Revision as of 02:48, 19 September 2015
E.artemisia
Combating Malaria with Synthetic Biology
One of the deadliest diseases in human history, malaria now claims over 600,000 lives a year. Our mission is to investigate the production of affordable antimalarial drugs by the means of synthetic biology. We are working with artemisinic acid producing E.coli cells obtained from Amyris, with the support of Zagaya, and operating via our innovative metabolic pathway. We have constructed BioBrick components of the system, which should allow for easier research and development in the future.
